Investment
Features
FeesSafety
Academy
More
Pluang+

Compare First Trust NASDAQ 100 Technology Index Fund (QTEC) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance

First Trust NASDAQ 100 Technology Index FundTrade
Relay Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

First Trust NASDAQ 100 Technology Index Fund vs Relay Therapeutics Inc. Common Stock — how do they compare? First Trust NASDAQ 100 Technology Index Fund trades at $329.84 (market cap $4.10B), while Relay Therapeutics Inc. Common Stock trades at $17.84 (market cap $3.82B). The key difference: First Trust NASDAQ 100 Technology Index Fund and Relay Therapeutics Inc. Common Stock are close in size by market cap, and First Trust NASDAQ 100 Technology Index Fund is trading nearer its 52-week high, Relay Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold First Trust NASDAQ 100 Technology Index Fund for 40 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.

QTECRLAY
Market Cap
$4.10B$3.82B
Volume
264,3034,332,079
Sector
Broad Market / FactorHealth
52-Week High
$340.28$20.75
52-Week Low
$207.03$6.03
Typical Hold Time
40 Days0 Days
Enterprise Value
—$2.93B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

First Trust NASDAQ 100 Technology Index Fund

QTEC, the First Trust NASDAQ-100-Technology Sector ETF, trades at $335.82, down 1.31% on the day. Technical indicators show a bullish trend from moving averages but caution from overbought RSI levels. The ETF provides equal-weighted exposure to the technology sector, with recent analysis highlighting its broader sector definition and liquidity advantages.

The outlook for QTEC is supported by bullish technical trends and its role in tech exposure, though overbought conditions and sector volatility present risks. Investment opportunity lies in diversified tech access, but investors face market sensitivity and valuation pressures inherent to technology stocks.

Relay Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QTEC
0% Buy100% Sell
Avg holding period · 40 Days
RLAY
100% Buy0% Sell
Avg holding period · 0 Days

About First Trust NASDAQ 100 Technology Index Fund

QTEC is an ETF that seeks to track the performance of the NASDAQ-100 Technology Sector Index. The fund provides targeted exposure to companies within the NASDAQ-100 that are classified as technology or telecommunications companies, focusing on firms involved in software, hardware, and related services. QTEC is a tool for investors seeking focused exposure to high-growth, large-cap technology companies listed on the NASDAQ exchange.

Read more on QTEC →

About Relay Therapeutics Inc. Common Stock

Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.

Read more on RLAY →